glp-1 and chronic kidney disease Potential kidney-protective other effects of receptor CKJ REVIEW GLP-1 receptor agonists

AMIA Annu Symp Proc:927, 2008

Then in May 2022, the FDA approved tirzepatide (Mounjaro) for type 2 diabetes the first GIP/GLP-1 dual agonist, hitting two incretin receptors at once and producing larger A1c and weight effects in the SURPASS program than any prior single-mechanism GLP-1

8 fluid ounces (236 ml) Serving Size: 1 Tablespoon (15mL) Servings Per Container: 16 16 fluid ounces (473 ml) Serving Size: 1 Tablespoon (15mL) Servings Per Container: 32 Other Ingredients: Organic non-GMO sunflower lecithin, vegetable glycerin Free of: Polysorbate 80, SOY, Sodium Benzoate, Ethyl Alcohol, Citric Acid, Artificial Sweeteners or GMO's Vegan Friendly, Gluten Free, Organic M M anufactured in the USA

Why it matters for Ipamorelin: GH is a counter-regulatory hormone to insulin

Retatrutide trials lasted 48-68 weeks